Liquid biopsies for residual disease and recurrence-Reference-Cited by-同舟云学术

Liquid biopsies for residual disease and recurrence

Published:2021-12 Issue:12 Volume:2 Page:1292-1313
ISSN:2666-6340
Container-title:Med
language:en
Short-container-title:Med

Author:

Wan Jonathan Chee Ming^ORCID,Mughal Tariq Imdadali,Razavi Pedram,Dawson Sarah-Jane^ORCID,Moss Esther Louise^ORCID,Govindan Ramaswamy,Tan Iain Beehuat,Yap Yoon-Sim^ORCID,Robinson William Allen,Morris Clive Dylan,Besse Benjamin,Bardelli Alberto,Tie Jeanne,Kopetz Scott,Rosenfeld Nitzan^ORCID

Publisher

Elsevier BV

Subject

General Medicine

Reference147 articles.

1. Les acides nucléiques du plasma sanguin chez l’homme;Mandel;C. R. Seances Soc. Biol. Fil.,1948

2. Free DNA in the serum of cancer patients and the effect of therapy;Leon;Cancer Res.,1977

3. Neoplastic characteristics of the DNA found in the plasma of cancer patients;Stroun;Oncology,1989

4. Soluble normal and mutated DNA sequences from single-copy genes in human blood;Sorenson;Cancer Epidemiol. Biomarkers Prev.,1994

5. Origin and quantification of circulating DNA in mice with human colorectal cancer xenografts;Thierry;Nucleic Acids Res.,2010

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. LBFextract: Unveiling transcription factor dynamics from liquid biopsy data;Computational and Structural Biotechnology Journal;2024-12

2. Clinical impact of circulating tumor DNA to track minimal residual disease in colorectal cancer patients. Hopes and limitations;ESMO Gastrointestinal Oncology;2024-06

3. LBFextract: unveiling transcription factor dynamics from liquid biopsy data;2024-05-05

4. Analytical validation of NeXT Personal®, an ultra-sensitive personalized circulating tumor DNA assay;Oncotarget;2024-03-14

5. Analytical Validation of NeXT Personal^®, an Ultra-sensitive Personalized Circulating Tumor DNA Assay;2024-01-17